Pipeline Therapeutics Announces a $1 Billion USD Global Licensing Deal with Janssen Pharma (J&J)
Pipeline Therapeutics and Janssen enter into a global licensing deal for PIPE-307. The deal is valued up to $1B USD.
top of page
Search
-
- Apr 15
- 6 min
Six synthetic biology companies that have made a mark
Portfolio Company, Ribbon Biolabs featured as one of the top 6 companies making a mark in Synthetic Biology
-
- Feb 27
- 2 min
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership
The generative AI drug company ramps up its internal pipeline and R&D portfolio, tapping into European markets, talent, and tech.
bottom of page